Buy 10 mg ETH-LAD Powder

Description

6-Ethyl-6-nor-lysergic acid diethylamide (also known as
N-Ethyl-nor-lysergic acid N,N-diethylamide,[1] N-Ethyl-nor-LSD,[1] and
ETH-LAD[1]) is a lesser-known novel psychedelic of the lysergamide
class. ETH-LAD is chemically similar to LSD and has a similar mechanism
of action, acting primarily by stimulating serotonin receptors in the
brain.

The human use of ETH-LAD was first documented by Alexander
Shulgin in his 1997 book TiHKAL (“Tryptamines I Have Known and Loved”).
It is noted for its “modified visual distortion” relative to LSD.[2] It
has been marketed alongside psychedelic lysergamides like 1P-LSD and
AL-LAD as a legal, grey-market alternative to LSD, and commercially
distributed through online research chemical vendors.

ETH-LAD has
been shown to be moderately to significantly more potent than LSD itself
in animal studies[3] with an active dose reported at between 40 and 100
micrograms. Anecdotal reports suggest that while it produces similar
effects to LSD at low to common doses, it displays a notably divergent
effects profile at higher doses, sometimes described as producing
“algorithmic” and “warped” visual and auditory distortions, combined
with a more “introspective” and “analytical”, if not more “neutral” head
space.

ETH-LAD has also been reported to more readily produce
adverse physical effects such as severe and persisting nausea,
temperature dysregulation, and generalized bodily discomfort,
particularly at higher doses. This has been speculated to owe itself to
an unusually sensitive and unpredictable dose-response curve, as low to
common dose experiences are generally described as being very manageable
and non-threatening.
Very little data exists about the
pharmacological properties, metabolism, and toxicity of ETH-LAD, and it
has little history of human usage. Along with its sensitive
dose-response and potentially concerning physical side effects, many
reports suggest that this substance may be overly difficult to use
safely for those who are not experienced with hallucinogens. It is
highly advised to use harm reduction practices if using this substance.

Common names
ETH-LAD
Substitutive name
6-Ethyl-6-nor-lysergic acid diethylamide
Systematic name
(6aR,9R)-N,N,7-Triethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide
Class Membership
Psychoactive class
Psychedelic
Chemical class
Lysergamide
Routes of Administration
WARNING: Always start with lower doses due to differences between
individual body weight, tolerance, metabolism, and personal sensitivity.
See responsible use section.